Trials / Unknown
UnknownNCT02219191
Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases
The Effect of Puerarin Tablets in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Chengdu PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the Effect of Puerarin tablets versus statins in treating metabolism syndrome in patients with chronic rheumatic diseases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | puerarin tablet 50 mg | |
| DRUG | Atorvastatin tablet 20 mg | Approval No.: H19990258 |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2014-08-18
- Last updated
- 2017-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02219191. Inclusion in this directory is not an endorsement.